Scorpion venom component III inhibits cell proliferation by modulating NF-κB activation in human leukemia cells

Song,Xiangfeng; Zhang,Guojun; Sun,Aiping; Guo,Jiqiang; Tian,Zhongwei; Wang,Hui; Liu,Yufeng

doi:10.3892/etm.2012.548

Scorpion venom component III inhibits cell proliferation by modulating NF-κB activation in human leukemia cells

Authors:
- Xiangfeng Song
- Guojun Zhang
- Aiping Sun
- Jiqiang Guo
- Zhongwei Tian
- Hui Wang
- Yufeng Liu
View Affiliations

Affiliations: Department of Pediatrics, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, Henan, P.R. China, Department of Immunology, Xinxiang Medical University, Xinxiang, Henan, P.R. China, Department of Dermatology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang, Henan, P.R. China
Published online on: April 17, 2012 https://doi.org/10.3892/etm.2012.548
Pages: 146-150

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Scorpion venom contains various groups of compounds that exhibit anticancer activity against a variety of malignancies through a poorly understood mechanism. While the aberrant activation of nuclear factor κB (NF‑κB) has been linked with hematopoietic malignancies, we hypothesized that scorpion venom mediates its effects by modulating the NF‑κB signaling pathway. In the present study, we examined the effects of scorpion venom component III (SVCIII) on the human leukemia cell lines THP‑1 and Jurkat and focused on the NF‑κB signaling pathway. Our results showed that SVCIII inhibited cell proliferation, caused cell cycle arrest at G1 phase and inhibited the expression of cell cycle regulatory protein cyclin D1 in a dose-dependent manner in THP‑1 and Jurkat cells. SVCIII also suppressed the constitutive NF‑κB activation through inhibition of the phosphorylation and degradation of IκBα. NF‑κB luciferase reporter activity was also inhibited by SVCIII. Our data suggest that SVCIII, a natural compound, may exert its antiproliferative effects by inhibiting the activation of NF‑κB and, thus, has potential use in the treatment of hematopoietic malignancies, alone or in combination with other agents.

View Figures

View References

1	Batista CVF, Pozo LD, Zamudio FZ, Contreras S, Becerril B, Wanke E and Possani LD: Proteomics of the venom from the Amazonian scorpion Tityus cambridgei and the role of prolines on mass spectrometry analysis of toxins. J Chromatogr B Analyt Technol Biomed Life Sci. 803:55–66. 2004. View Article : Google Scholar : PubMed/NCBI
2	Zargan J, Sajad M, Umar S, Naime M, Ali S and Khan HA: Scorpion (Androctonus crassicauda) venom limits growth of transformed cells (SH-SY5Y and MCF-7) by cytotoxicity and cell cycle arrest. Exp Mol Pathol. 91:447–454. 2011.
3	Gao F, Li H, Chen YD, Yu XN, Wang R and Chen XL: Upregulation of PTEN involved in scorpion venom-induced apoptosis in a lymphoma cell line. Leuk Lymphoma. 50:633–641. 2009. View Article : Google Scholar : PubMed/NCBI
4	Zargan J, Sajad M, Umar S, Naime M, Ali S and Khan HA: Scorpion (Odontobuthus doriae) venom induces apoptosis and inhibits DNA synthesis in human neuroblastoma cells. Mol Cell Biochem. 348:173–181. 2011.
5	Hayden MS, West AP and Ghosh S: NF-κB and the immune response. Oncogene. 25:6758–6780. 2006.
6	Garg A and Aggarwal BB: Nuclear transcription factor-kappaB as a target for cancer drug development. Leukemia. 16:1053–1068. 2002. View Article : Google Scholar : PubMed/NCBI
7	Escárcega RO, Fuentes-Alexandro S, García-Carrasco M, Gatica A and Zamora A: The transcription factor nuclear factor-κB and cancer. Clin Oncol (R Coll Radiol). 19:154–161. 2007.
8	Hanahan D and Weinberg RA: The hallmarks of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar
9	Gupta SD and Gomes A, Debnath A, Saha A and Gomes A: Apoptosis induction in human leukemic cells by a novel protein Bengalin, isolated from Indian black scorpion venom: through mitochondrial pathway and inhibition of heat shock proteins. Chem Biol Interact. 183:293–303. 2010. View Article : Google Scholar
10	Das Gupta S, Debnath A, Saha A, Giri B, Tripathi G, Vedasiromoni JR and Gomes A: Indian black scorpion (Heterometrus bengalensis Koch) venom induced antiproliferative and apoptogenic activity against human leukemic cell lines U937 and K562. Leukemia Res. 31:817–825. 2007.
11	Fan S, Sun Z, Jiang D, Dai C, Ma Y, Zhao Z, Liu H, Wu Y, Cao Z and Li W: BmKCT toxin inhibits glioma proliferation and tumor metastasis. Cancer Lett. 291:158–166. 2010. View Article : Google Scholar : PubMed/NCBI
12	Fu YJ, Yin LT, Liang AH, Zhang CF, Wang W, Chai BF, Yang JY and Fan XJ: Therapeutic potential of chlorotoxin-like neurotoxin from the Chinese scorpion for human gliomas. Neurosci Lett. 412:62–67. 2007. View Article : Google Scholar : PubMed/NCBI
13	Wang WX and Ji YH: Scorpion venom induces glioma cell apoptosis in vivo and inhibits glioma tumor growth in vitro. J Neurooncol. 73:1–7. 2005. View Article : Google Scholar : PubMed/NCBI
14	D’Suze G, Rosales A, Salazar V and Sevcik C: Apoptogenic peptides from Tityus discrepans scorpion venom acting against the SKBR3 breast cancer cell line. Toxicon. 56:1497–1505. 2010.
15	Zhang YY, Wu LC, Wang ZP, Wang ZX, Jia Q, Jiang GS and Zhang WD: Anti-proliferation effect of polypeptide extracted from scorpion venom on human prostate cancer cells in vitro. J Clin Med Res. 1:24–31. 2009.PubMed/NCBI
16	Omran MAA: In vitro anticancer effect of scorpion Leiurus quinquestriatus and Egyptian Cobra venom on human breast and prostate cancer cell lines. J Med Sci. 3:66–86. 2003.
17	Bonizzi G and Karin M: The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25:280–288. 2004. View Article : Google Scholar : PubMed/NCBI
18	Yamamoto M and Takeda K: Role of nuclear IkappaB proteins in the regulation of host immune responses. J Infect Chemother. 14:265–269. 2008. View Article : Google Scholar : PubMed/NCBI
19	Wu Y and Zhou BP: TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion. Br J Cancer. 102:639–644. 2010. View Article : Google Scholar : PubMed/NCBI
20	Sarkar FH, Li Y, Wang Z and Kong D: NF-kappaB signaling pathway and its therapeutic implications in human diseases. Int Rev Immunol. 27:293–319. 2008. View Article : Google Scholar : PubMed/NCBI
21	Nishikori M: Classical and alternative NF-κB activation pathways and their roles in lymphoid malignancies. J Clin Exp Hematopathol. 45:15–24. 2005.
22	Wong JH, Lui VW, Umezawa K, Ho Y, Wong EY, Ng MH, Cheng SH, Tsang CM, Tsao SW and Chan AT: A small molecule inhibitor of NF-kappaB, dehydroxymethylepoxyquinomicin (DHMEQ), suppresses growth and invasion of nasopharyngeal carcinoma (NPC) cells. Cancer Lett. 287:23–32. 2010. View Article : Google Scholar : PubMed/NCBI
23	Warfel JM and D’Agnillo F: Anthrax lethal toxin enhances TNF-induced endothelial VCAM-1 expression via an IFN regulatory factor-1-dependent mechanism. J Immunol. 180:7516–7524. 2008. View Article : Google Scholar : PubMed/NCBI
24	Qiao Q, Nozaki Y, Sakoe K, Komatsu N and Kirito K: NF-κB mediates aberrant activation of HIF-1 in malignant lymphoma. Exp Hematol. 38:1199–1208. 2010.
25	Huber AV, Saleh L, Prast J, Haslinger P and Knöfler M: Human chorionic gonadotrophin attenuates NF-kappaB activation and cytokine expression of endometriotic stromal cells. Mol Hum Reprod. 13:595–604. 2007. View Article : Google Scholar : PubMed/NCBI
26	Karin M and Ben-Neriah Y: Phosphorylation meets ubiquitination: the control of NF-kB activity. Annu Rev Immunol. 18:621–663. 2000. View Article : Google Scholar : PubMed/NCBI
27	Korn SH, Wouters EF, Vos N and Janssen-Heininger YM: Cytokine-induced activation of nuclear factor-kappa B is inhibited by hydrogen peroxide through oxidative inactivation of IkappaB kinase. J Biol Chem. 276:35693–35700. 2001. View Article : Google Scholar : PubMed/NCBI
28	Kumar A, Takada Y, Boriek AM and Aggarwal BB: Nuclear factor-κB: its role in health and disease. J Mol Med. 82:434–448. 2004.
29	Sethi G, Sung B and Aggarwal BB: Nuclear factor-kappaB activation: from bench to bedside. Exp Biol Med (Maywood). 233:21–31. 2008. View Article : Google Scholar : PubMed/NCBI
30	Biliran H Jr, Wang Y, Banerjee S, Xu H, Heng H, Thakur A, Bollig A, Sarkar FH and Liao JD: Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line. Clin Cancer Res. 11:6075–6086. 2005. View Article : Google Scholar : PubMed/NCBI
31	Sung B, Ahn KS and Aggarwal BB: Noscapine, a benzylisoquinoline alkaloid, sensitizes leukemic cells to chemotherapeutic agents and cytokines by modulating the NF-kappaB signaling pathway. Cancer Res. 70:3259–3268. 2010. View Article : Google Scholar : PubMed/NCBI